Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazine

• CELEX: Implementing Regulation (EU) 2024/2781
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 4, Azoxystrobin, the date is replaced by ‘31 May 2027’;

(2)

in the sixth column, expiration of approval, of row 5, Imazalil, the date is replaced by ‘31 May 2027’;

(3)

in the sixth column, expiration of approval, of row 8, Kresoxim-methyl, the date is replaced by ‘31 May 2027’;

(4)

in the sixth column, expiration of approval, of row 9, Fluroxypyr, the date is replaced by ‘15 February 2027’;

(5)

in the sixth column, expiration of approval, of row 10, Tefluthrin, the date is replaced by ‘31 May 2027’;

(6)

in the sixth column, expiration of approval, of row 11, Oxyfluorfen, the date is replaced by ‘31 May 2027’;

(7)

in the sixth column, expiration of approval, of row 16, Terbuthylazine, the date is replaced by ‘31 May 2027’;

(8)

in the sixth column, expiration of approval, of row 18, 8-hydroxyquinoline, the date is replaced by ‘31 December 2025’;

(9)

in the sixth column, expiration of approval, of row 37, Candida oleophila strain O, the date is replaced by ‘31 May 2027’;

(10)

in the sixth column, expiration of approval, of row 39, Paecilomyces fumosoroseus  strain FE 9901, the date is replaced by ‘31 May 2027’;

(11)

in the sixth column, expiration of approval, of row 62, Chlorantraniliprole, the date is replaced by ‘31 May 2027’;

(12)

in the sixth column, expiration of approval, of row 76, Metobromuron, the date is replaced by ‘31 May 2027’;

(13)

in the sixth column, expiration of approval, of row 77, Aminopyralid, the date is replaced by ‘31 May 2027’.